Stay updated on Nivolumab +/- Ipilimumab in NECs Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab in NECs Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added a Publications entry citing the J Clin Oncol article for NIPINEC and noted that publications are automatically filled from PubMed. Revision history updated to v3.4.3.
    Difference
    0.3%
    Check dated 2026-03-11T16:44:27.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior Notice about lapse in government funding and Revision: v3.4.1 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:14:52.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A general site notice about potential delays due to a lapse in government funding was added, and the page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T04:57:17.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Minor UI/text updates: added a 'Show glossary' option; updated footer labels to 'Last Update Submitted that Met QC Criteria' (from 'Last Update Submitted that met QC Criteria') and to 'No FEAR Act Data' (from 'No FEAR Act data'); updated the revision tag to 'Revision: v3.4.0' (from 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T02:16:29.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added, replacing Revision: v3.3.3. This metadata update does not affect the study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-01-14T01:36:19.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 elements were removed.
    Difference
    0.1%
    Check dated 2025-12-23T09:51:04.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab in NECs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.